J 2023

Anti-Cancer Properties of Resveratrol: A Focus on Its Impact on Mitochondrial Functions

KURSVIETIENE, Lolita, Dalia M KOPUSTINSKIENE, Inga STANEVICIENE, Ausra MONGIRDIENE, Kateřina KUBOVÁ et. al.

Basic information

Original name

Anti-Cancer Properties of Resveratrol: A Focus on Its Impact on Mitochondrial Functions

Authors

KURSVIETIENE, Lolita, Dalia M KOPUSTINSKIENE, Inga STANEVICIENE, Ausra MONGIRDIENE, Kateřina KUBOVÁ (203 Czech Republic, belonging to the institution), Ruta MASTEIKOVÁ (203 Czech Republic, belonging to the institution) and Jurga BERNATONIENE (guarantor)

Edition

Antioxidants, Basel, MDPI, 2023, 2076-3921

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30104 Pharmacology and pharmacy

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 7.000 in 2022

RIV identification code

RIV/00216224:14160/23:00133208

Organization unit

Faculty of Pharmacy

UT WoS

001136105900001

Keywords in English

resveratrol; cancer; mitochondria

Tags

Tags

International impact, Reviewed
Změněno: 5/4/2024 07:46, Mgr. Daniela Černá

Abstract

V originále

Cancer is one of the most serious public health issues worldwide, demanding ongoing efforts to find novel therapeutic agents and approaches. Amid growing interest in the oncological applications of phytochemicals, particularly polyphenols, resveratrol-a naturally occurring polyphenolic stilbene derivative-has emerged as a candidate of interest. This review analyzes the pleiotropic anti-cancer effects of resveratrol, including its modulation of apoptotic pathways, cell cycle regulation, inflammation, angiogenesis, and metastasis, its interaction with cancer stem cells and the tumor microenvironment. The effects of resveratrol on mitochondrial functions, which are crucial to cancer development, are also discussed. Future research directions are identified, including the elucidation of specific molecular targets, to facilitate the clinical translation of resveratrol in cancer prevention and therapy.